Triple-negative breast cancer (TNBC) is defined by the absence of estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 (HER2) amplification and accounts for ~15% of breast cancer cases [1]. Here, ESR1 is linked to breast cancer.